Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables
about
Efficacy of psychostimulant drugs for amphetamine abuse or dependencePharmacotherapy of amphetamine-type stimulant dependence: an updateUtilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.Cognitive enhancement as a treatment for drug addictionsRandomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine usePoor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine.Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatmentPredictors of time to relapse in amphetamine-type substance users in the matrix treatment program in Iran: a Cox proportional hazard model application.Boundary conditions of methamphetamine cravingCognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders.Factors associated with caregiver stability in permanent placements: a classification tree approach.Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals.Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence.Stereotype threat and social function in opioid substitution therapy patients.Cognitive rehabilitation for individuals with opioid use disorder: A randomized controlled trial.Working memory predicts methamphetamine hair concentration over the course of treatment: moderating effect of impulsivity and implications for dual-systems model.
P2860
Q24198261-31A92DC4-C51E-4AAE-92F7-000137CA3DE8Q26991936-44B6E440-949C-4C51-9B09-4518460768D9Q33449522-F488CFFC-BE34-43C0-9998-CE14B0DAF78CQ33671505-C048F0CD-BA15-44D1-941D-CA47BB482BF8Q34284329-DBEC7A9B-9BD2-49B0-B84F-72741F4D3763Q34315501-C4BC6FC2-6776-495A-A412-671B6ACC0270Q35235473-BD299611-391E-4FFD-8DA0-23163806F92EQ35607225-F0B6ED14-6FE8-4D98-B2BC-E38BF5AA4D77Q36085088-A0DEF056-A269-46B0-88D5-FCDFD73042C0Q36315579-FED385B7-F796-47BE-8ED1-DCC21227C560Q36813681-743EC112-D08D-4545-8A88-E8D14C1532B6Q37087257-0AFEBF42-6F7A-4B34-8185-F705F0679D7BQ37622273-277C6F83-3BF6-4650-B154-90BC2E338966Q39009620-7DF3A0DD-778E-4D4D-9515-7B1DA140E1C8Q39029911-65CCB1B3-1017-47F3-96FC-697BB623D647Q44351311-FCB93B39-6A6B-4625-82D3-70FAC24BA8C2Q48345861-4EE74807-CE78-4985-B5E9-AA26F22C839A
P2860
Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting adherence to treatm ...... logical and drug use variables
@en
Predicting adherence to treatm ...... ogical and drug use variables.
@nl
type
label
Predicting adherence to treatm ...... logical and drug use variables
@en
Predicting adherence to treatm ...... ogical and drug use variables.
@nl
prefLabel
Predicting adherence to treatm ...... logical and drug use variables
@en
Predicting adherence to treatm ...... ogical and drug use variables.
@nl
P2093
P2860
P1476
Predicting adherence to treatm ...... logical and drug use variables
@en
P2093
Aimee-Noelle Swanson
Andy C Dean
Ari D Kalechstein
Catherine A Sugar
Christina M R Kitchen
Edythe D London
Keith G Heinzerling
Steven Shoptaw
P2860
P356
10.1016/J.DRUGALCDEP.2009.06.008
P577
2009-07-15T00:00:00Z